Abstract
Human medicines European public assessment report (EPAR): Temybric Ellipta, fluticasone furoate,umeclidinium,vilanterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 12/06/2019, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have